![PDF) Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects PDF) Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects](https://www.researchgate.net/profile/Juergen-Machann/publication/12968128/figure/fig2/AS:601628386275335@1520450793321/figure-fig2_Q320.jpg)
PDF) Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects
![PDF) Troglitazone, an antidiabetic agent, inhibits cholesterol biosynthesis through a mechanism independent of peroxisome proliferator-activated receptor-γ PDF) Troglitazone, an antidiabetic agent, inhibits cholesterol biosynthesis through a mechanism independent of peroxisome proliferator-activated receptor-γ](https://i1.rgstatic.net/publication/12965030_Troglitazone_an_antidiabetic_agent_inhibits_cholesterol_biosynthesis_through_a_mechanism_independent_of_peroxisome_proliferator-activated_receptor-g/links/0fcfd50e48acbc3558000000/largepreview.png)
PDF) Troglitazone, an antidiabetic agent, inhibits cholesterol biosynthesis through a mechanism independent of peroxisome proliferator-activated receptor-γ
![PDF) Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects PDF) Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects](https://www.researchgate.net/profile/Juergen-Machann/publication/12968128/figure/tbl1/AS:601628386275336@1520450793412/Characteristic-of-the-study-population_Q320.jpg)
PDF) Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects
![PDF) A case of hepatocyte nuclear factor-1α diabetes/MODY3 masquerading as Type 1 diabetes in a Mexican-American adolescent and responsive to a low dose of sulfonylurea PDF) A case of hepatocyte nuclear factor-1α diabetes/MODY3 masquerading as Type 1 diabetes in a Mexican-American adolescent and responsive to a low dose of sulfonylurea](https://i1.rgstatic.net/publication/12965439_A_case_of_hepatocyte_nuclear_factor-1a_diabetesMODY3_masquerading_as_Type_1_diabetes_in_a_Mexican-American_adolescent_and_responsive_to_a_low_dose_of_sulfonylurea/links/543fb7ed0cf21227a11afbeb/largepreview.png)
PDF) A case of hepatocyte nuclear factor-1α diabetes/MODY3 masquerading as Type 1 diabetes in a Mexican-American adolescent and responsive to a low dose of sulfonylurea
![PDF) Prevalence of patients reaching the targets of good control in normal clinical practice - A cohort-based study in type 2 diabetes PDF) Prevalence of patients reaching the targets of good control in normal clinical practice - A cohort-based study in type 2 diabetes](https://i1.rgstatic.net/publication/12713174_Prevalence_of_patients_reaching_the_targets_of_good_control_in_normal_clinical_practice_-_A_cohort-based_study_in_type_2_diabetes/links/53eb3f1b0cf28f342f45238c/largepreview.png)
PDF) Prevalence of patients reaching the targets of good control in normal clinical practice - A cohort-based study in type 2 diabetes
![PDF) Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects PDF) Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects](https://www.researchgate.net/profile/Juergen-Machann/publication/12968128/figure/fig3/AS:601628386271256@1520450793357/figure-fig3_Q320.jpg)
PDF) Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects
![PDF) Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas PDF) Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas](https://i1.rgstatic.net/publication/12965418_Homeostasis_model_assessment_as_a_clinical_index_of_insulin_resistance_in_type_2_diabetic_patients_treated_with_sulfonylureas/links/53d9a0920cf2631430c7d7b7/largepreview.png)